Plasma 25-hydroxycholecalciferol in oral sulfonylurea treated diabetes mellitus - PubMed (original) (raw)
Comparative Study
Plasma 25-hydroxycholecalciferol in oral sulfonylurea treated diabetes mellitus
J Stĕpán et al. Horm Metab Res. 1982 Feb.
Abstract
In oral sulfonylurea treated diabetics, decreased plasma 25-hydroxycholecalciferol and increased activity of bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion was found when compared with control subjects. In stepwise regression analysis significant relationships were found between bone isoenzyme, urinary hydroxyproline excretion, serum calcium levels and blood glucose levels. The partial correlation and multivariate regression analysis showed that in oral sulfonylurea treated patients, but not in insulin treated patients, the activity of bone isoenzyme of serum alkaline phosphatase was significantly inverse dependent on the 25-hydroxycholecalciferol levels in plasma. Oral sulfonylurea agents which are known to induce the hepatic microsomal system seem to be an additional factor to poor control of diabetes, leading to osteopathy.
Similar articles
- Bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in thyrotoxicosis.
Broulik PD, Stĕpán JJ, Límanová Z, Pacovský V. Broulik PD, et al. Endocrinol Exp. 1985 Sep;19(3):165-9. Endocrinol Exp. 1985. PMID: 3876205 - Bone isoenzyme of serum alkaline phosphatase in diabetes mellitus.
Stĕpán J, Havránek T, Formánková J, Skrha J, Skrha F, Pacovský V. Stĕpán J, et al. Clin Chim Acta. 1980 Jul 17;105(1):75-81. doi: 10.1016/0009-8981(80)90094-7. Clin Chim Acta. 1980. PMID: 7398086 - Urinary hydroxyproline and serum alkaline phosphatase in sickle cell disease.
Mohammed SM, Suleiman SA, Addae SK, Annobil SH, Adzaku FK, Kadoummi OF, Richards JT. Mohammed SM, et al. Clin Chim Acta. 1991 Dec 16;203(2-3):285-94. doi: 10.1016/0009-8981(91)90301-r. Clin Chim Acta. 1991. PMID: 1777988 - [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB. Tattersall RB. Journ Annu Diabetol Hotel Dieu. 1984:183-91. Journ Annu Diabetol Hotel Dieu. 1984. PMID: 6443219 Review. French. No abstract available. - Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD. Prendergast BD. Clin Pharm. 1984 Sep-Oct;3(5):473-85. Clin Pharm. 1984. PMID: 6435940 Review.
Cited by
- The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.
Pittas AG, Lau J, Hu FB, Dawson-Hughes B. Pittas AG, et al. J Clin Endocrinol Metab. 2007 Jun;92(6):2017-29. doi: 10.1210/jc.2007-0298. Epub 2007 Mar 27. J Clin Endocrinol Metab. 2007. PMID: 17389701 Free PMC article. Review. - Osteoporosis in type II diabetes.
Isaia G, Bodrato L, Carlevatto V, Mussetta M, Salamano G, Molinatti GM. Isaia G, et al. Acta Diabetol Lat. 1987 Oct-Dec;24(4):305-10. doi: 10.1007/BF02742962. Acta Diabetol Lat. 1987. PMID: 3439401
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical